글로벌 의료용 대마초 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

의료용 대마초 시장 분석

의료용 대마초 시장은 최근 몇 년 동안 다양한 의학적 상태에 대한 치료적 이점에 대한 인식이 증가함에 따라 상당한 성장을 경험했습니다. 여러 지역에서 합법화 노력이 가속화됨에 따라 의료용 대마초 제품에 대한 수요가 증가하고 있습니다. 이 시장은 만성 통증, 간질 , 정신 건강 장애와 같은 상태에 맞게 조정된 오일, 캡슐, 식용 제품을 포함한 광범위한 제품을 포함합니다. 재배 기술 및 추출 공정 의 발전과 같은 최근의 발전으로 제품 품질과 효능이 개선되어 시장 확장이 더욱 촉진되었습니다. 또한 소비자의 인식과 수용이 증가하고 정부 정책이 지원되면서 시장의 긍정적인 전망에 기여하는 주요 요인입니다. 연구를 통해 대마초의 잠재적 이점이 계속 밝혀짐에 따라 의료용 대마초 시장은 지속적인 성장을 향해 나아가고 있으며 제약 회사와 의료 서비스 제공자 모두에게 새로운 기회를 제공합니다.

의료용 대마 시장 규모

글로벌 의료용 대마초 시장 규모는 2023년에 210억 6천만 달러로 평가되었으며, 2031년까지 1,089억 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 22.80%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

의료용 대마초 시장 동향

“ 개인화된 대마초 제품에 대한 수요”

The medical cannabis market is witnessing transformative trends driven by innovation and evolving consumer preferences. A notable trend is the growing demand for personalized cannabis products, where consumers seek tailored formulations to address specific health conditions and individual needs. Innovations in cannabis extraction and formulation techniques are enabling the development of diverse product offerings, such as targeted oils and infused edibles, that enhance therapeutic effects. In addition, advancements in technology, including the use of artificial intelligence and data analytics in cultivation and supply chain management, are optimizing production processes and ensuring product consistency. Overall, these trends reflect a shift towards more effective, customized medical cannabis solutions, catering to the diverse needs of patients and driving market growth.

Report Scope and Medical Cannabis Market Segmentation  

Medical Cannabis Market Definition

Medical cannabis refers to the use of the cannabis plant and its derivatives for therapeutic purposes. It encompasses a variety of products, including oils, capsules, tinctures, and topical formulations, containing cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD). Medical cannabis is prescribed to alleviate symptoms associated with various health conditions, including chronic pain, epilepsy, multiple sclerosis, nausea from chemotherapy, and anxiety. Its use is often regulated by laws that vary by region, and it is typically recommended when conventional treatments have proven ineffective.

Medical Cannabis Market Dynamics

Drivers

• Increasing Acceptance and Legalization

The increasing acceptance of medical cannabis among healthcare professionals and medical cannabis patients is a significant driver of market growth. As research continues to unveil the therapeutic benefits of cannabinoids for various medical conditions, healthcare providers are more inclined to recommend cannabis as a treatment option. This shift in perception has led to greater patient awareness and willingness to consider medical cannabis for managing chronic pain, anxiety, and other ailments. Moreover, the legalization of medical cannabis in numerous regions has further facilitated its integration into mainstream healthcare. This regulatory change legitimizes its use and encourages investment in research and product development, thus expanding the market. The combined effect of these factors is expected to foster significant growth in the medical cannabis market.

•  Rising Prevalence of Chronic Diseases

The rising incidence of chronic diseases, including cancer, epilepsy, and multiple sclerosis, has created a substantial demand for effective pain management and therapeutic solutions, significantly boosting the medical cannabis market. Patients suffering from these conditions often experience severe pain, discomfort, and a range of debilitating symptoms that conventional treatments may not adequately address. Medical cannabis, with its diverse array of cannabinoids, offers a natural alternative that can alleviate pain and improve quality of life. As healthcare providers increasingly recognize the potential of cannabis-based treatments, more patients are being referred to medical cannabis as a viable option. This growing acceptance, alongside ongoing research demonstrating the efficacy of cannabis for symptom relief, continues to propel market growth as patients seek effective and holistic approaches to managing their health conditions.

Opportunities

• Integration with Traditional Healthcare

Collaborations between cannabis companies and traditional healthcare providers present a significant opportunity for market growth in the medical cannabis sector. By partnering with healthcare professionals, cannabis companies can enhance the legitimacy of their products and foster trust among potential patients. These collaborations can lead to the development of educational programs and clinical guidelines, making healthcare providers more comfortable recommending cannabis therapies as part of a comprehensive treatment plan. As healthcare providers gain confidence in the efficacy and safety of medical cannabis, they are more likely to advocate for its use, ultimately increasing patient access to these therapies. This integration broadens the market reach of cannabis products and contributes to the overall acceptance of medical cannabis within mainstream healthcare, driving sustained market expansion.

• Advancements in Research and Development

Ongoing research into the therapeutic benefits of cannabinoids is unlocking new opportunities in the medical cannabis market. As scientists and healthcare professionals continue to explore the medicinal properties of various cannabinoids, they are discovering innovative applications for conditions ranging from chronic pain and anxiety to neurological disorders. This research has led to the development of new medical cannabis products, expanding the variety of treatment options available to patients. Such advancements cater to diverse patient needs and enhance the efficacy and safety profiles of cannabis-based therapies. As more clinical studies validate the benefits of these products, they are likely to gain acceptance among healthcare providers and patients alike. This expansion of product offerings presents a lucrative opportunity for companies to capture a larger share of the growing medical cannabis market, ultimately improving patient outcomes and satisfaction.

Restraints/Challenges

• Lack of Standardized Regulations

The medical cannabis market faces significant challenges due to the lack of standardized regulations and the varying legal frameworks across different regions. Each jurisdiction has its own rules governing the cultivation, distribution, and sale of medical cannabis, creating a complex landscape for companies to navigate. This regulatory inconsistency often results in confusion and delays in market entry for new players. Companies may spend considerable time and resources understanding local laws, obtaining necessary licenses, and ensuring compliance with diverse regulations. These hurdles can deter potential investors and limit the growth of the market. Consequently, the absence of a unified regulatory approach poses a significant challenge to the expansion and accessibility of medical cannabis products globally.

•  Competition from Traditional Therapies

Established pharmaceutical treatments continue to hold a significant share of the healthcare market, often backed by extensive research, clinical trials, and regulatory approvals. These conventional therapies are widely prescribed by healthcare professionals and have a long-standing reputation for safety and efficacy. As a result, patients and doctors may be hesitant to consider medical cannabis products as viable alternatives, especially in serious conditions like cancer and chronic pain. The familiarity and trust in traditional medications can hinder the adoption of medical cannabis, despite its potential benefits. This reliance on established treatments limits the market growth for cannabis-based therapies, as healthcare professionals may prioritize familiar pharmaceutical options over newer, less understood cannabis products. This restraint creates a challenge for the medical cannabis market to gain traction among patients and healthcare providers.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Medical Cannabis Market Scope

The market is segmented on the basis of product, source, species, derivatives, application, route of administration, treatment type, end user, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Oil
• Medical Cannabis Capsules
• Patch
• Whole Flower
• Ground Flower
• Vape Pen
• Dried Medical Cannabis
• Creams & Moisturizers
• Masks & Serum
• Cleanser
• Others

Source

• Natural
• Synthetic

Species

• Cannabis Indica
• Cannabis Sativa
• Hybrid

Application

• Alzheimer’s Disease
• Appetite Loss
• Cancer
• Inflammatory Bowel Diseases
• Eating Disorders
• Epilepsy
• Autism
• Mental Health Conditions
• Multiple Sclerosis
• Pain Management
• Nausea
• Muscle Spasms
• Wasting Syndrome (Cachexia)
• Elevate Mood
• Depression and Sleep Disorders
• Anxiety
• Others

Derivatives

• Cannabidiol (CBD)
• Tetrahydrocannabinol (THC) / Delta-8-Tetrahydrocannabinol
• Cannabinol (CBN)
• Cannabicyclol (CBL)
• Cannabichromene (CBC)
• Cannabigerol (CBG)
• Others

Treatment Type

• Expectorant
• Antiviral
• Analgesic
• Aphrodisiac
• Psychedelic
• Others

Route of Administration

• Oral Solutions and Capsules
• Smoking
• Vaporizers
• Topicals
• Others

End User

• Pharmaceutical Industry
• Research and Development Centers
• Homecare Setting
• Hospitals
• Rehab Centers
• Others

Distribution Channel

• B2B
• B2C

 Medical Cannabis Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, product, source, species, derivatives, application, route of administration, treatment type, end user, and distribution channel as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to dominate the global medical cannabis market due to the increasing investment in medical cannabis. The U.S. is expected to dominate the North America region due to the legalization of medical cannabis use. Germany is expected to dominate the Europe region due to the increasing demand for medical cannabis in emerging markets and expansion. Australia is expected to dominate the Asia-Pacific region due to the presence of key manufacturers and advanced technological processes.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Medical Cannabis Market Share

시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우세입니다. 위에 제공된 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.

시장에서 운영되는 의료용 대마초 시장 리더는 다음과 같습니다.

• MediPharm Labs Inc. (캐나다)
• 틸레이(캐나다)
• 오로라 캐나비스(캐나다)
• JAZZ Pharmaceuticals Inc. (영국) (GW Pharmaceuticals plc)
• HEXO Corp. (캐나다) (Zenabis Global Ltd)
• 크레스코 랩스(미국)
• Peace Naturals Project Inc. (캐나다)
• 캐노피 그로스 코퍼레이션(캐나다)
• 의료용 마리화나 주식회사(미국)
• 씨앗 저장고(미국)
• 에코젠 바이오사이언스(미국)
• CANNABIS SEEDS USA (미국)
• Seeds For Me (미국)
• 험볼트씨드컴퍼니(미국)
• 추출물(미국)
• 월드 클래스 대마초 씨앗(Crop King Seeds)(캐나다)
• BARNEY'S FARM(네덜란드)
• FOLIUM BIOSCIENCES(미국)
• PharmaHemp(영국)
• Elixinol Global Limited(호주)
• ENDOCA(네덜란드)
• 하모니(영국)
• MARY'S Nutritionals, LLC(미국)
• 순수 비율(미국)
• 그리니치 바이오사이언스(Greenwich Biosciences, Inc.) (미국)
• 업스테이트 엘리베이터 공급 회사(미국)
• 아포테카나(미국)
• BOL Pharma(이스라엘)
• IDT Australia (호주)

의료용 대마초 시장의 최신 동향

• 2023년 2월, 글로벌 대마 유통을 전문으로 하는 캐나다 기업인 Aurora Cannabis Inc.는 MedReleaf Australia와 협력하여 호주 시장을 위한 새로운 의료용 대마 브랜드인 CraftPlant를 출시했습니다. CraftPlant의 초기 제품에는 Greendae, Navana, HiVolt의 세 가지 제품이 포함되며, 이 모든 제품은 현재 의사의 처방을 통해 구입할 수 있습니다. 각 품종은 높은 THC 농도를 자랑하며 Aurora의 선도적인 과학 및 유전학 회사인 Occo에서 개발한 프리미엄 품종에서 공급되며 엄격한 EU-GMP 승인 표준에 따라 생산된 10g 용기에 포장됩니다.
• 2023년 7월, 인도의 종양학 회사인 Carer는 의료용 대마초와 카나비디올의 인증 제조업체인 Wholeleaf와의 파트너십을 발표했습니다. 이 협업은 간병인을 위한 영양, 물리 치료 및 정신 건강 서비스를 포함한 포괄적인 지원을 제공하여 암 환자의 전반적인 웰빙을 개선하는 것을 목표로 합니다. Ayush 부처로부터 전국적으로 제품을 제조하고 판매할 수 있는 공식 승인을 받은 CARER와 Wholeleaf는 서비스를 결합하여 암 치료를 위한 전체적인 솔루션을 제공합니다.
• 2023년 9월, 호주인이 의료용 대마초를 구하도록 돕는 것으로 알려진 병원인 Alternaleaf가 영국으로의 확장을 발표했습니다. 연구에 따르면 영국은 증가하는 수요에 힘입어 유럽에서 두 번째로 큰 의료용 대마초 시장이 될 것으로 보입니다. 영국에서 오피오이드 중독 사례가 360,000건 이상 보고됨에 따라 전문가들은 의료용 대마초가 불필요하게 자주 처방되는 오피오이드에 대한 실행 가능한 대안이 될 수 있다고 제안합니다.
• 2022년 4월, Medi Cane Health Inc.와 Dr. Reddy's Laboratories Ltd.는 독일에서 의료용 대마초 제품을 출시했습니다. 이 협력은 이 지역에서 증가하는 의료용 대마초 솔루션 수요를 충족하는 것을 목표로 합니다. 이 제품의 출시는 독일 환자들을 위한 치료용 대마초 옵션에 대한 접근성을 확대하는 데 있어 중요한 단계를 나타냅니다.
• 2022년 4월, 뉴욕시는 7개의 의료용 마리화나 사업체가 모든 성인에게 제품을 판매하도록 승인을 받은 지 불과 한 달 만에 처음으로 합법적인 마리화나 판매를 목격했습니다. 이 이정표는 주의 대마초 환경에서 상당한 변화를 의미하며, 의학적 용도를 넘어 접근성을 확대합니다. 이 이니셔티브는 규제된 시장을 만들고 지역 경제에 이바지하며 소비자 안전을 보장하는 것을 목표로 합니다.

SKU-52961